Correction to: Nedosiran in primary hyperoxaluria subtype 3: results from a phase I, single-dose study (PHYOX4)

Detalles Bibliográficos
Autores principales: Goldfarb, David S., Lieske, John C., Groothoff, Jaap, Schalk, Gesa, Russell, Kerry, Yu, Shuli, Vrhnjak, Blaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241720/
https://www.ncbi.nlm.nih.gov/pubmed/37273015
http://dx.doi.org/10.1007/s00240-023-01455-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241720/
https://www.ncbi.nlm.nih.gov/pubmed/37273015
http://dx.doi.org/10.1007/s00240-023-01455-1

Ejemplares similares